• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单磷酰脂质A通过Toll样受体4(TLR4)诱导先天性免疫反应,以增强小鼠鼻咽部不可分型流感嗜血杆菌和卡他莫拉菌的清除。

Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.

作者信息

Hirano Takashi, Kodama Satoru, Kawano Toshiaki, Maeda Kazuhiko, Suzuki Masashi

机构信息

Department of Otolaryngology, Oita University, Japan.

出版信息

FEMS Immunol Med Microbiol. 2011 Dec;63(3):407-17. doi: 10.1111/j.1574-695X.2011.00866.x. Epub 2011 Oct 5.

DOI:10.1111/j.1574-695X.2011.00866.x
PMID:22092567
Abstract

Acute otitis media (AOM) is one of the most common infectious diseases in children. Nontypeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis, Gram-negative bacteria, are considered major pathogens of AOM and respiratory tract infections. In this study, we used monophosphoryl lipid A (MPL) as a Toll-like receptor (TLR4) agonist to induce innate immune responses before challenge with NTHi and M. catarrhalis to enhance bacterial clearance from the nasopharynx. Mice were intranasally administered 40, 10, or 1 μg of MPL and challenged with NTHi and M. catarrhalis 12 and 24 h later. At 6 and 12 h after the bacterial challenge, the mice were killed and nasal washes were collected. The numbers of NTHi, M. catarrhalis, and inflammatory cells were quantitated. Inoculation of MPL produced a significant reduction in the number of bacteria recovered from the nasopharynx at 6 and/or 12 h after the bacterial challenge, when compared with control mice. The effect was dose dependent. MPL inoculation also induced the early accumulation of neutrophils in the nasopharynx after exposure to bacteria. MPL is effective for eliciting clearance of both NTHi and M. catarrhalis from the nasopharynx. These results indicate the possibility of a new strategy against Gram-negative bacterial infection that involves the stimulation of the innate immune system by TLR4 agonists such as MPL.

摘要

急性中耳炎(AOM)是儿童最常见的传染病之一。不可分型流感嗜血杆菌(NTHi)和卡他莫拉菌这两种革兰氏阴性菌被认为是AOM和呼吸道感染的主要病原体。在本研究中,我们使用单磷酰脂质A(MPL)作为Toll样受体(TLR4)激动剂,在受到NTHi和卡他莫拉菌攻击之前诱导先天免疫反应,以增强从鼻咽部清除细菌的能力。给小鼠经鼻内给予40、10或1μg的MPL,并在12小时和24小时后用NTHi和卡他莫拉菌进行攻击。在细菌攻击后6小时和12小时,处死小鼠并收集鼻腔灌洗液。对NTHi、卡他莫拉菌和炎性细胞的数量进行定量。与对照小鼠相比,接种MPL后,在细菌攻击后6小时和/或12小时,从鼻咽部回收的细菌数量显著减少。这种作用呈剂量依赖性。接种MPL还可诱导在接触细菌后,中性粒细胞在鼻咽部早期聚集。MPL对于从鼻咽部清除NTHi和卡他莫拉菌均有效。这些结果表明,通过MPL等TLR4激动剂刺激先天免疫系统,可能是一种对抗革兰氏阴性菌感染的新策略。

相似文献

1
Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.单磷酰脂质A通过Toll样受体4(TLR4)诱导先天性免疫反应,以增强小鼠鼻咽部不可分型流感嗜血杆菌和卡他莫拉菌的清除。
FEMS Immunol Med Microbiol. 2011 Dec;63(3):407-17. doi: 10.1111/j.1574-695X.2011.00866.x. Epub 2011 Oct 5.
2
Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization.单磷酰脂质A通过鼻内免疫增强不可分型流感嗜血杆菌特异性黏膜和全身免疫反应。
Int J Pediatr Otorhinolaryngol. 2017 Jun;97:5-12. doi: 10.1016/j.ijporl.2017.03.018. Epub 2017 Mar 19.
3
Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.用rLP4/rLP6/UspA2蛋白联合RC529水性制剂进行鼻内免疫后,不可分型流感嗜血杆菌鼻腔定植的减少。
Vaccine. 2004 Sep 3;22(25-26):3449-56. doi: 10.1016/j.vaccine.2004.02.027.
4
Toll-like receptor 4 plays an important role to enhance bacterial clearance from the nose in synergy with triggering receptor expressed on myeloid cells (TREM)-1 expression on polymorphonuclear neutrophils.Toll样受体4与多形核中性粒细胞上髓样细胞表达的触发受体(TREM)-1协同作用,在增强鼻腔细菌清除方面发挥重要作用。
Int J Pediatr Otorhinolaryngol. 2018 Sep;112:27-33. doi: 10.1016/j.ijporl.2018.06.025. Epub 2018 Jun 14.
5
The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.在用外膜蛋白进行鼻内免疫后,Toll样受体4在引发针对不可分型流感嗜血杆菌的获得性免疫反应中的作用。
Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1657-65. doi: 10.1016/j.ijporl.2009.08.015. Epub 2009 Sep 17.
6
A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.单次鼻腔给予 fms 样酪氨酸激酶受体 3 配体,而不是腹腔内应用,可增强鼻咽部非典型流感嗜血杆菌特异性的长期黏膜免疫应答。
Vaccine. 2010 Mar 16;28(13):2510-6. doi: 10.1016/j.vaccine.2010.01.043. Epub 2010 Jan 29.
7
Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.鼻腔内接种编码 P6 蛋白和免疫刺激复合物的质粒 DNA 可引发鼻咽部非典型流感嗜血杆菌特异性长期黏膜免疫应答。
Vaccine. 2011 Feb 24;29(10):1881-90. doi: 10.1016/j.vaccine.2010.12.129. Epub 2011 Jan 13.
8
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.天然免疫分子对肺炎链球菌、卡他莫拉菌和不可分型流感嗜血杆菌的抗菌活性。
BMC Infect Dis. 2004 May 5;4:12. doi: 10.1186/1471-2334-4-12.
9
Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.Toll样受体4在急性中耳炎小鼠模型天然免疫反应中的作用
FEMS Immunol Med Microbiol. 2007 Feb;49(1):75-83. doi: 10.1111/j.1574-695X.2006.00186.x.
10
Risk of repeated Moraxella catarrhalis colonization is increased in children with Toll-like receptor 4 Asp299Gly polymorphism.Toll 样受体 4 Asp299Gly 多态性增加儿童反复莫拉氏菌定植的风险。
Pediatr Infect Dis J. 2013 Nov;32(11):1185-8. doi: 10.1097/INF.0b013e31829e6df2.

引用本文的文献

1
Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomes.针对卡他莫拉菌的免疫需要鸟苷酸结合蛋白和半胱天冬酶-11-NLRP3 炎性小体。
EMBO J. 2023 Mar 15;42(6):e112558. doi: 10.15252/embj.2022112558. Epub 2023 Feb 10.
2
Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice.联合佐剂可提高鼻内灭活伪狂犬病疫苗在小鼠中的保护效力。
Front Microbiol. 2022 Sep 15;13:976220. doi: 10.3389/fmicb.2022.976220. eCollection 2022.
3
Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications.
纳米载体用于有效递药:调节固有免疫以管理感染及相关并发症。
J Nanobiotechnology. 2022 Aug 19;20(1):380. doi: 10.1186/s12951-022-01582-8.
4
The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma.脓毒症和创伤后免疫功能障碍的代谢基础。
Front Immunol. 2020 May 29;11:1043. doi: 10.3389/fimmu.2020.01043. eCollection 2020.
5
Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.通过宿主导向疗法减轻抗菌药物耐药性的影响:当前进展、展望和挑战。
mBio. 2018 Jan 30;9(1):e01932-17. doi: 10.1128/mBio.01932-17.
6
Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.鼻腔内的铝(氧)羟化物能使吸附的抗原诱导特异性全身和黏膜免疫应答。
Hum Vaccin Immunother. 2017 Nov 2;13(11):2688-2694. doi: 10.1080/21645515.2017.1365995. Epub 2017 Sep 21.
7
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.Toll 样受体 4 激动剂的免疫生物学:从内毒素耐受到免疫佐剂。
Shock. 2013 Dec;40(6):451-62. doi: 10.1097/SHK.0000000000000042.
8
Immunotherapy for tularemia.土拉菌病的免疫疗法。
Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19.
9
Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.Toll样受体4激动性抗体可增强针对流感病毒和肺炎链球菌共感染所致重症肺炎的天然免疫。
Clin Vaccine Immunol. 2013 Jul;20(7):977-85. doi: 10.1128/CVI.00010-13. Epub 2013 May 1.